Seok-Jin Kim - Publications

Affiliations: 
School of Energy & Chemical Engineering Ulsan National Institute of Science and Technology, Ulsan, South Korea 

88 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kim HK, Kang W, Sinn DH, Lee JH, Kim WS, Kim SJ. Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance. The Korean Journal of Internal Medicine. PMID 30935195 DOI: 10.3904/kjim.2018.196  0.72
2019 Cho J, Yoon J, Kim Y, Oh D, Kim SJ, Ahn J, Suh GY, Nam SJ, Mitchell SA. Linguistic Validation of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Korean. Journal of Global Oncology. 1-10. PMID 30917069 DOI: 10.1200/JGO.18.00193  0.44
2019 Han GF, Chen ZW, Jeon JP, Kim SJ, Noh HJ, Shi XM, Li F, Jiang Q, Baek JB. Low-Temperature Conversion of Alcohols into Bulky Nanoporous Graphene and Pure Hydrogen with Robust Selectivity on CaO. Advanced Materials (Deerfield Beach, Fla.). e1807267. PMID 30815929 DOI: 10.1002/adma.201807267  0.76
2019 Shin SH, Kim YJ, Lee D, Cho D, Ko YH, Cho J, Park WY, Park D, Kim SJ, Kim WS. Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes. Leukemia & Lymphoma. 1-10. PMID 30774000 DOI: 10.1080/10428194.2019.1573998  0.76
2019 Shin J, Ko YH, Oh SY, Yoon DH, Lee JO, Kim JS, Park Y, Shin HJ, Kim SJ, Won JH, Yoon SS, Kim WS, Koh Y. Body Cavity-Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30764603 DOI: 10.4143/crt.2018.555  0.72
2018 Kim SJ, Yoon SE, Kim WS. Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review. Journal of Hematology & Oncology. 11: 140. PMID 30567593 DOI: 10.1186/s13045-018-0687-0  0.72
2018 Mahmood J, Anjum MAR, Shin SH, Ahmad I, Noh HJ, Kim SJ, Jeong HY, Lee JS, Baek JB. Encapsulating Iridium Nanoparticles Inside a 3D Cage-Like Organic Network as an Efficient and Durable Catalyst for the Hydrogen Evolution Reaction. Advanced Materials (Deerfield Beach, Fla.). e1805606. PMID 30387226 DOI: 10.1002/adma.201805606  0.76
2018 Yi JH, Ryu KJ, Ko YH, Kim WS, Kim SJ. Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma. Cytokine. PMID 30327172 DOI: 10.1016/j.cyto.2018.10.009  0.72
2018 Hong J, Cho J, Ko YH, Kim SJ, Kim WS. Validation of the Marginal Zone Lymphoma International Prognostic Index. Annals of Hematology. PMID 30310985 DOI: 10.1007/s00277-018-3516-1  0.72
2018 Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, ... ... Kim SJ, et al. Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30221329 DOI: 10.1007/s00259-018-4163-4  0.72
2018 Jung H, Yoo HY, Lee SH, Shin S, Kim SC, Lee S, Joung JG, Nam JY, Ryu D, Yun JW, Choi JK, Ghosh A, Kim KK, Kim SJ, Kim WS, et al. Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in followed by mutations in and . Oncotarget. 9: 32882. PMID 30214692 DOI: 10.18632/oncotarget.26080  0.72
2018 Jeong SH, Song HN, Park JS, Yang DH, Koh Y, Yoon SS, Lee HW, Eom HS, Won JH, Kim WS, Kim SJ. Allogeneic stem cell transplantation for patients with natural killer/T-cell lymphoid malignancy: a multicenter analysis comparing upfront and salvage transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30064012 DOI: 10.1016/j.bbmt.2018.07.034  0.72
2018 Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, ... ... Kim SJ, et al. A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30056546 DOI: 10.1007/s00259-018-4093-1  0.72
2018 Kim SJ, Hyeon J, Cho I, Ko YH, Kim WS. Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30025443 DOI: 10.4143/crt.2018.191  0.72
2018 Lee H, Oh D, Yang K, Ko YH, Ahn YC, Kim WS, Kim SJ. Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 29986575 DOI: 10.4143/crt.2018.190  0.72
2018 Lim SW, Ryu KJ, Lee H, Ko YH, Kim WS, Kim SJ. Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer/T-cell lymphoma. Leukemia & Lymphoma. 1-9. PMID 29979096 DOI: 10.1080/10428194.2018.1480772  0.72
2018 Oh SY, Kim WS, Kang HJ, Lee JH, Huh SJ, Kim SJ, Yoon DH, Hong JY, Lee WS, Kim HJ, Won JH, Park BB, Lee SI, Suh C. Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study. Annals of Hematology. PMID 29947974 DOI: 10.1007/s00277-018-3387-5  0.72
2018 Fan J, Lee HO, Lee S, Ryu DE, Lee S, Xue C, Kim SJ, Kim K, Barkas N, Park PJ, Park WY, Kharchenko PV. Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data. Genome Research. PMID 29898899 DOI: 10.1101/gr.228080.117  0.52
2018 Cho J, Kim SJ, Park S, Yoo KH, Ki CS, Ko Y, Kim WS. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma. Annals of Hematology. PMID 29627879 DOI: 10.1007/s00277-018-3313-x  0.72
2018 Hong JY, Yoon DH, Suh C, Kim WS, Kim SJ, Jo JC, Kim JS, Lee WS, Oh SY, Park Y, Kim SY, Lee MH, Lee HS, Do YR. Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis. Annals of Hematology. PMID 29619501 DOI: 10.1007/s00277-018-3317-6  0.72
2018 Yamaguchi M, Suzuki R, Kim SJ, Ko YH, Oguchi M, Asano N, Miyazaki K, Terui Y, Kubota N, Maeda T, Kobayashi Y, Amaki J, Soejima T, Saito B, Shimoda E, et al. Early disease progression in patients with localized NK/T-cell lymphoma treated with concurrent chemoradiotherapy. Cancer Science. PMID 29601137 DOI: 10.1111/cas.13597  0.72
2018 Yoo KH, Kang D, Kim IR, Choi EK, Kim JS, Yoon SS, Lee CH, Park S, Kim SJ, Kim K, Kim WS, Jung CW, Choi HJ, Jang JH, Cho J. Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study. Bone Marrow Transplantation. PMID 29403022 DOI: 10.1038/s41409-018-0097-5  0.72
2018 Mahmood J, Kim SJ, Noh HJ, Jung SM, Li F, Seo JM, Baek JB. Robust 3D cage-like ultramicroporous network structure with high gas uptake capacities. Angewandte Chemie (International Ed. in English). PMID 29392856 DOI: 10.1002/anie.201800218  0.76
2018 Kim SJ, Mahmood J, Kim C, Han GF, Kim SW, Jung SM, Zhu G, De Yoreo JJ, Kim G, Baek JB. Defect-Free Encapsulation of Fe0 in 2D Fused Organic Networks as a Durable Oxygen Reduction Electrocatalyst. Journal of the American Chemical Society. PMID 29298388 DOI: 10.1021/jacs.7b10663  0.76
2017 Yi JH, Kim SJ, Kim WS. Brentuximab vedotin: clinical updates and practical guidance. Blood Research. 52: 243-253. PMID 29333400 DOI: 10.5045/br.2017.52.4.243  0.72
2017 Yi JH, Kim SJ, Kim WS. Recent advances in understanding and managing T-cell lymphoma. F1000research. 6: 2123. PMID 29259783 DOI: 10.12688/f1000research.12573.1  0.72
2017 Tang T, Khoo LP, Lim C, Ham JS, Kim SJ, Hong H, Phipps C, Lee YS, Tao M, Quek R, Farid M, Lin T, Kim WS, Lim ST. Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers. Blood Cancer Journal. 7: 653. PMID 29242582 DOI: 10.1038/s41408-017-0030-y  0.72
2017 Hong J, Kim SJ, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, et al. Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma. Oncotarget. 8: 92171-92182. PMID 29190906 DOI: 10.18632/oncotarget.20988  0.72
2017 Kang D, Cho J, Kim I, Kim MK, Kim WS, Kim SJ. Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 29121713 DOI: 10.4143/crt.2017.207  0.72
2017 Ham JS, Park HY, Ryu KJ, Ko YH, Kim WS, Kim SJ. Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma. Oncotarget. 8: 76231-76240. PMID 29100307 DOI: 10.18632/oncotarget.19301  0.72
2017 Seo J, Kim WS, Kim JS, Kim SJ, Lee JH, Hong JS, Lee GW, Oh SY, Lee JH, Yoon DH, Lee WS, Kim HJ, Kwak JY, Kang HJ, Jo JC, et al. Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial. Blood Research. 52: 200-206. PMID 29043235 DOI: 10.5045/br.2017.52.3.200  0.72
2017 Kim HY, Jang MA, Kim HJ, Kim SJ, Kim WS, Kim SH. Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphoma. Blood Research. 52: 193-199. PMID 29043234 DOI: 10.5045/br.2017.52.3.193  0.72
2017 Ko JH, Kang CI, Cho SY, Ha YE, Lee NY, Kim SJ, Chung DR, Peck KR, Song JH. Mycobacterium abscessus glossitis. The Lancet. Infectious Diseases. 17: 1098. PMID 28948933 DOI: 10.1016/S1473-3099(17)30525-X  0.44
2017 Li F, Zhao X, Mahmood J, Okyay MS, Jung SM, Ahmad I, Kim SJ, Han GF, Park N, Baek JB. Macroporous Inverse Opal-Like Mo2C with Incorporated Mo Vacancies for Significantly Enhanced Hydrogen Evolution. Acs Nano. PMID 28692795 DOI: 10.1021/acsnano.7b04205  0.76
2017 Md GI, Oh D, Kim WS, Kim SJ, Ko YH, Woo KI, Kim YD, Ahn YC. Low Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-cell Lymphoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28618774 DOI: 10.4143/crt.2017.182  0.72
2017 Heo MH, Park HY, Ko YH, Kim WS, Kim SJ. IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma. Journal of Cancer. 8: 1018-1024. PMID 28529614 DOI: 10.7150/jca.17358  0.72
2017 Cho J, Kang D, Kim IR, Kim WS, Ferrell B, Kim SJ. Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28361524 DOI: 10.4143/crt.2017.091  0.72
2017 Kim HS, Lee JY, Lim SH, Cho J, Kim SJ, Jang JH, Kim WS, Jung CW, Kim K. Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma. Nutrition (Burbank, Los Angeles County, Calif.). 36: 67-71. PMID 28336110 DOI: 10.1016/j.nut.2016.06.009  0.72
2017 Kim SJ, Basur MS, Park CK, Chong S, Kang YG, Kim MJ, Jeong JS, Kim TK. Crosscultural Adaptation and Validation of the Korean Version of the New Knee Society Knee Scoring System. Clinical Orthopaedics and Related Research. PMID 28265885 DOI: 10.1007/s11999-017-5307-8  0.52
2017 Mahmood J, Li F, Jung SM, Okyay MS, Ahmad I, Kim SJ, Park N, Jeong HY, Baek JB. An efficient and pH-universal ruthenium-based catalyst for the hydrogen evolution reaction. Nature Nanotechnology. PMID 28192390 DOI: 10.1038/nnano.2016.304  0.76
2017 Kim IR, Kim SH, Ok ON, Kim SH, Lee S, Choi E, Kim SJ, Yoon DH, Lee MH. Sexual problems in male vs. female non-Hodgkin lymphoma survivors: prevalence, correlates, and associations with health-related quality of life. Annals of Hematology. PMID 28184983 DOI: 10.1007/s00277-017-2940-y  0.6
2017 Jung H, Yoo HY, Lee SH, Shin S, Kim SC, Lee S, Joung JG, Nam JY, Ryu D, Yun JW, Choi JK, Ghosh A, Kim KK, Kim SJ, Kim WS, et al. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. Oncotarget. PMID 28152507 DOI: 10.18632/oncotarget.14928  0.72
2016 Hong JY, Ryu KJ, Lee JY, Park C, Ko YH, Kim WS, Kim SJ. Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphoma. Hematological Oncology. PMID 27943355 DOI: 10.1002/hon.2374  0.72
2016 Park HY, Lee SB, Yoo HY, Kim SJ, Kim WS, Kim JI, Ko YH. Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma. Oncotarget. PMID 27835906 DOI: 10.18632/oncotarget.13239  0.72
2016 Seo S, Hong JY, Yoon S, Yoo C, Park JH, Lee JB, Park CS, Huh J, Lee Y, Kim KW, Ryu JS, Kim SJ, Kim WS, Yoon DH, Suh C. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era. Oncotarget. PMID 27764777 DOI: 10.18632/oncotarget.12734  0.72
2016 Kim SJ, Bang SM, Choi YS, Jo DY, Kim JS, Lee H, Eom HS, Yoon DH, Suh C, Lee JJ, Hong J, Lee JH, Koh Y, Kim K, Yoon SS, et al. Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party. Blood Research. 51: 193-199. PMID 27722131 DOI: 10.5045/br.2016.51.3.193  0.6
2016 Shin SY, Lee ST, Kim HY, Park CH, Kim HJ, Kim JW, Kim SJ, Kim WS, Kim SH. Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas. Blood Research. 51: 181-186. PMID 27722129 DOI: 10.5045/br.2016.51.3.181  0.72
2016 Moon SH, Lee AY, Kim WS, Kim SJ, Cho YS, Choe YS, Kim BT, Lee KH. Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma. Leukemia & Lymphoma. 1-8. PMID 27718766 DOI: 10.1080/10428194.2016.1236380  0.72
2016 Kim SJ, Hong JS, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, et al. Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study. Oncotarget. PMID 27713132 DOI: 10.18632/oncotarget.12459  0.72
2016 Na YG, Chang MJ, Eom SH, Kim SJ, Park SC, Kim TK. Coronal alignment on the single-limb stance radiograph in posterolateral rotatory instability, osteoarthritis and healthy knees. The Knee. PMID 27692866 DOI: 10.1016/j.knee.2016.09.003  0.52
2016 Son SM, Ha SY, Yoo HY, Oh D, Kim SJ, Kim WS, Ko YH. Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27687005 DOI: 10.1038/modpathol.2016.56  0.72
2016 Song JG, Kim SJ, Woo WJ, Kim Y, Oh IK, Ryu GH, Lee Z, Lim JH, Park J, Kim H. Effect of Al2O3 Deposition on Performance of Top-Gated Monolayer MoS2 based Field Effect Transistor. Acs Applied Materials & Interfaces. PMID 27681666 DOI: 10.1021/acsami.6b07271  0.36
2016 Kim SJ, Shin HT, Lee HO, Kim NK, Yun JW, Hwang JH, Kim K, Park WY. Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis. Oncotarget. PMID 27634910 DOI: 10.18632/oncotarget.12029  0.52
2016 Yoon DH, Kim SJ, Jeong SH, Shin DY, Bae SH, Hong J, Park SK, Yhim HY, Yang DH, Lee H, Kang HJ, Lee MH, Eom HS, Kwak JY, Lee JH, et al. Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008). Oncotarget. PMID 27542213 DOI: 10.18632/oncotarget.11319  0.72
2016 Park S, Kim K, Jang JH, Kim SJ, Kim WS, Jung CW. Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation. Oncotarget. PMID 27494893 DOI: 10.18632/oncotarget.10988  0.72
2016 Jung KS, Cho SH, Kim SJ, Ko YH, Kim WS. Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma. International Journal of Hematology. PMID 27456462 DOI: 10.1007/s12185-016-2068-1  0.72
2016 Park S, Kim K, Jang JH, Kim SJ, Kim WS, Chung DR, Kang CI, Peck KR, Jung CW. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients. The Journal of Infection. PMID 27394404 DOI: 10.1016/j.jinf.2016.06.011  0.72
2016 Ryu D, Kim HJ, Joung JG, Lee HO, Bae JS, Kim SJ, Kim H, Park WY, Kim K. Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker. Oncotarget. PMID 27223072 DOI: 10.18632/oncotarget.9478  0.56
2016 Maeng CH, Ko YH, Lim DH, Kang ES, Choi JY, Kim WS, Kim SJ. Comparison of Total Body Irradiation (TBI) Conditioning with non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T and NK-cell Non-Hodgkin Lymphoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 27188204 DOI: 10.4143/crt.2015.476  0.72
2016 Jung KS, Cho SH, Kim SJ, Ko YH, Kang ES, Kim WS. L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia. Journal of Hematology & Oncology. 9: 41. PMID 27091029 DOI: 10.1186/s13045-016-0271-4  0.72
2016 Kim SH, Lee S, Kim SH, Ok ON, Kim IR, Choi E, Kang YK, Kim SJ, Lee MH. Unmet needs of non-Hodgkin lymphoma survivors in Korea: prevalence, correlates, and associations with health-related quality of life. Psycho-Oncology. PMID 27073128 DOI: 10.1002/pon.4136  0.52
2016 Lee HS, Min CK, Lee JJ, Kim K, Kim SJ, Yoon DH, Eom HS, Lee H, Lee WS, Shin HJ, Lee JH, Park Y, Jo JC, Do YR, Mun YC, et al. The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea. Annals of Hematology. PMID 27052989 DOI: 10.1007/s00277-016-2660-8  0.72
2016 Shin DY, Kim SJ, Yoon DH, Park Y, Kong JH, Kim JA, Kim BS, Kim HJ, Won JH, Park SK, Kim WS. Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis. Cancer Chemotherapy and Pharmacology. PMID 26984211 DOI: 10.1007/s00280-016-3005-y  0.72
2016 Kim HS, Ryu KJ, Ko YH, Kim HJ, Kim SH, Kim WS, Kim SJ. Macrophage inflammatory protein 1 alpha (MIP-1α) may be associated with poor outcome in patients with extranodal NK/T-cell lymphoma. Hematological Oncology. PMID 26928433 DOI: 10.1002/hon.2283  0.72
2016 Shin SY, Lee ST, Kim HJ, Oh YL, Kim SJ, Kim WS, Kim SH. Usefulness of Flow Cytometric Analysis for Detecting Leptomeningeal Diseases in Non-Hodgkin Lymphoma. Annals of Laboratory Medicine. 36: 209-14. PMID 26915608 DOI: 10.3343/alm.2016.36.3.209  0.72
2016 Maeng CH, Ahn SW, Ryu SY, Han S, Ko YH, Ji JH, Kim WS, Kim SJ. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy. The Korean Journal of Internal Medicine. PMID 26898595 DOI: 10.3904/kjim.2014.222  0.72
2016 Kim SJ, Yoon DH, Jaccard A, Chng WJ, Lim ST, Hong H, Park Y, Chang KM, Maeda Y, Ishida F, Shin DY, Kim JS, Jeong SH, Yang DH, Jo JC, et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. The Lancet. Oncology. PMID 26873565 DOI: 10.1016/S1470-2045(15)00533-1  0.72
2016 Lee SE, Kang SY, Yoo HY, Kim SJ, Kim WS, Ko YH. Clonal relationships in recurrent B-cell lymphomas. Oncotarget. PMID 26848863 DOI: 10.18632/oncotarget.7132  0.72
2016 Yoo HY, Kim P, Kim WS, Lee SH, Kim S, Kang SY, Jang HY, Lee JE, Kim J, Kim SJ, Ko YH, Lee S. Frequent CTLA4-CD28 gene fusion in diverse types of T cell lymphoma. Haematologica. PMID 26819049 DOI: 10.3324/haematol.2015.139253  0.36
2016 Kim SM, Park S, Oh DR, Ahn YC, Ko YH, Kim SJ, Kim WS. Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability. Annals of Hematology. PMID 26729202 DOI: 10.1007/s00277-015-2581-y  0.72
2015 Lee S, Kim MJ, Kim JS, Oh SY, Kim SJ, Kwon YH, Chung IY, Kang JH, Yang DH, Kang HJ, Yoon DH, Kim WS, Kim HJ, Suh C. Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study. Blood Research. 50: 242-7. PMID 26770952 DOI: 10.5045/br.2015.50.4.242  0.72
2015 Kim JH, Kim WS, Ryu K, Kim SJ, Park C. CD79B limits response of diffuse large B cell lymphoma to ibrutinib. Leukemia & Lymphoma. 1-10. PMID 26699656 DOI: 10.3109/10428194.2015.1113276  0.72
2015 Kim SJ, Choi JY, Hyun SH, Ki CS, Oh D, Ahn YC, Ko YH, Choi S, Jung SH, Khong PL, Tang T, Yan X, Lim ST, Kwong YL, Kim WS, et al. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. The Lancet. Haematology. 2: e66-74. PMID 26687611 DOI: 10.1016/S2352-3026(15)00002-2  0.72
2015 Park S, Jung CW, Kim K, Kim SJ, Kim WS, Jang JH. Iron deficient erythropoiesis might play key role in development of anemia in cancer patients. Oncotarget. PMID 26517509 DOI: 10.18632/oncotarget.5658  0.72
2015 Lee MY, Kim HS, Lee JY, Lim SH, Kang ES, Ko YH, Kim SJ, Kim WS. Efficacy and feasibility of autologous stem cell transplantation in patients with diffuse large B-cell lymphoma with secondary central nervous system involvement. International Journal of Hematology. PMID 26493833 DOI: 10.1007/s12185-015-1874-1  0.72
2015 Oh D, Ahn YC, Kim SJ, Kim WS, Ko YH. Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. International Journal of Radiation Oncology, Biology, Physics. 93: 677-83. PMID 26461010 DOI: 10.1016/j.ijrobp.2015.07.2267  0.72
2015 Lee HG, Kim SY, Kim I, Kim YK, Kim JA, Kim YS, Lee HS, Park J, Kim SJ, Shim H, Eom HS, Park BB, Lee J, Park SK, Cheong JW, et al. Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation. Blood Research. 50: 160-6. PMID 26457283 DOI: 10.5045/br.2015.50.3.160  0.52
2015 Lim SH, Park S, Jang JH, Kim K, Kim HJ, Kim SH, Kang CI, Chung DR, Peck KR, Lee J, Cha HS, Koh EM, Ko YH, Kim WS, Jung CW, ... Kim SJ, et al. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis. Annals of Hematology. PMID 26453074 DOI: 10.1007/s00277-015-2523-8  0.72
2015 Kim SJ, Ryu KJ, Hong M, Ko YH, Kim WS. Erratum to: The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients. Journal of Hematology & Oncology. 8: 112. PMID 26449540 DOI: 10.1186/s13045-015-0200-y  0.72
2015 Oh SY, Kim WS, Kim JS, Chae YS, Lee GW, Eom HS, Ryoo HM, Lee S, Kim SJ, Yoon DH, Won JH, Hong J, Park J, Lee SM, Hong JY, et al. A phase II study of Oxaliplatin and Prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial. Leukemia & Lymphoma. 1-23. PMID 26413982 DOI: 10.3109/10428194.2015.1099650  0.72
2015 Park S, Kim K, Jang JH, Kim SJ, Kim WS, Kang ES, Jung CW. KIR alloreactivity based on the receptor-ligand model is associated with improved clinical outcomes of allogeneic hematopoietic stem cell transplantation: Result of single center prospective study. Human Immunology. PMID 26407827 DOI: 10.1016/j.humimm.2015.09.009  0.72
2015 Lee SH, Kim JS, Kim J, Kim SJ, Kim WS, Lee S, Ko YH, Yoo HY. A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients. Haematologica. PMID 26405154 DOI: 10.3324/haematol.2015.133074  0.72
2015 Lee JH, Lee GY, Kim SJ, Kim KH, Jeon ES, Lee KH, Kim BT, Choi JY. Imaging Findings and Literature Review of (18)F-FDG PET/CT in Primary Systemic AL Amyloidosis. Nuclear Medicine and Molecular Imaging. 49: 182-90. PMID 26279691 DOI: 10.1007/s13139-015-0338-0  0.72
2015 Hong JY, Ko YH, Kim SJ, Kim WS. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and update. Current Opinion in Oncology. 27: 392-8. PMID 26258272 DOI: 10.1097/CCO.0000000000000210  0.72
2015 Koh MS, Kim WS, Kim SJ, Oh SY, Yoon DH, Lee SI, Hong J, Song MK, Shin HJ, Kwon JH, Kim HJ, Do YR, Suh C, Kim HJ. Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study. International Journal of Hematology. PMID 26210384 DOI: 10.1007/s12185-015-1845-6  0.72
2015 Lim AY, Lee JH, Jung KS, Gwag HB, Kim do H, Kim SJ, Lee GY, Kim JS, Kim HJ, Lee SY, Lee JE, Jeon ES, Kim K. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience. The Korean Journal of Internal Medicine. 30: 496-505. PMID 26161016 DOI: 10.3904/kjim.2015.30.4.496  0.72
2015 Na YG, Eom SH, Kim SJ, Chang MJ, Kim TK. The use of navigation in medial opening wedge high tibial osteotomy can improve tibial slope maintenance and reduce radiation exposure. International Orthopaedics. PMID 26156725 DOI: 10.1007/s00264-015-2880-x  0.52
2015 Song YD, Jain NP, Kim SJ, Kwon SK, Chang MJ, Chang CB, Kim TK. Is Knee Magnetic Resonance Imaging Overutilized in Current Practice? Knee Surgery & Related Research. 27: 95-100. PMID 26060608 DOI: 10.5792/ksrr.2015.27.2.95  0.52
Show low-probability matches.